GPGI 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- GPGI reported 3rd quarter results in line with expectations, with pro forma adjusted net sales of $509.6 million, up approximately 5% from the prior year; pro forma adjusted EBITDA of $146.3 million, up approximately 7%; and pro forma adjusted EBITDA margins of 28.7%, up approximately 60 basis points.
- GPGI generated approximately $81 million in pro forma adjusted free cash flow in the 3rd quarter, higher than the prior year.
- CompoSecure delivered record adjusted net sales of $140.7 million, up approximately 16%, and record adjusted EBITDA of $61.2 million, up approximately 23%; adjusted EBITDA margins were 43.5%, up approximately 230 basis points year over year.
- CompoSecure reduced manufacturing waste by approximately 30% over the past year through its ROS focus.
- Husky reported adjusted net sales of $368.9 million, up 0.5% from the prior year; pro forma adjusted EBITDA of $88.8 million, down 0.9%; and pro forma adjusted EBITDA margins of 24.1%, down approximately 30 basis points.
- Husky's total orders increased 7% year over year and 4% sequentially in the 3rd quarter; aftermarket tooling orders rose 19% and spare parts orders rose 17% year over year.
- Husky's sales recovered year over year, with a return to growth in systems sales and high single-digit growth in its service business; margins expanded approximately 500 basis points quarter over quarter.
- Husky's pipeline was up approximately 16% year over year, total orders were up approximately 7%, and recurring aftermarket orders were up approximately 13% year over year through the 3rd quarter.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good day, and thank you for standing by. Welcome to the GPGI third quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, GPGI's corporate secretary.
Please go ahead. Good morning, and welcome to GPGI's third quarter conference call.
This morning's remarks will include forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially, including those disclosed in our SEC filings available at sec.gov and on our investor relations website. Additionally, definitions and reconciliations for non-GAAP measures used today appear in today's press release and earnings presentation, which are available in our SEC filings and on our investor relations website. As a reminder, following the Resolute Holdings spin-off, current GAAP interpretation requires GPGI to account for GPGI Holdings, including our CompoSecure and Husky businesses, under the equity method of accounting. With that, I will turn the call over to our Executive Chairman, Dave Cote.
Morning, everyone. In the third quarter, GPGI delivered results in line with our expectations. The results were driven by continued strength at CompoSecure and improving demand at Husky. Starting with CompoSecure, ROS is taking hold deeper in the organization, and its impact on growth and profitability continues. The company delivered record sales and adjusted EBITDA, margin expansion, and strong operating performance in the quarter. With robust demand from an expanding base of leading issuers, CompoSecure is well-positioned to close out 2026, while Graham and his team are also doing the necessary seed planning for 2027 and beyond. We're proud of the cultural change that has occurred at Compo. The results you see are an outcome of a high-performance culture combined with smart strategic investments in a business that has a great position in a good industry.
Turning to Husky, we've owned the business for approximately 10 months, and while the performance to date has not lived up to our high expectations, Husky is a fundamentally great business. We faced severe macro headwinds shortly after closing when the Iran war created a resin price shock that significantly impacted customer purchasing behavior overnight. With the evolving demand picture, we have also faced margin headwinds due primarily to cost actions that have taken us longer to realize than anticipated. That said, I have full confidence in the trajectory of the business as we see demand improving, our pipeline and orders accelerating, cost actions back on track, and margins stabilizing with clear opportunity for Husky to accelerate performance in 2027. We're focused on driving cultural change at Husky to execute today while also making the investments necessary for the company to achieve its potential.
This work was made more challenging with the market issues in the first half of the year, but our commitment to doing what is necessary in the business is unwavering. Husky does have a great position in a good industry. Market disruptions happen, and we're using this as a culture change accelerant. Husky performed in line with our expectations this quarter, with sales recovering year-over-year and margins improving sequentially, led by the return to growth in systems and strength in our service business. While we still face some delays in orders converting to revenue and customer deferrals on aftermarket tooling, excluding service, we see a clear uplift in orders, which provides the momentum and backlog coverage for a strong start to 2027. Specifically, our pipeline is up approximately 16% year-over-year.
Total orders are up approximately 7% year-over-year, and recurring aftermarket orders are up approximately 13% year-over-year through the third quarter. Notably, we anticipate further acceleration in the fourth quarter given a strengthening, high-confidence near-term pipeline, particularly for new systems. This momentum is not unexpected, as Husky serves an underlying market that grows consistently. This means that while demand can be deferred, especially for new system purchases, as we saw in the first two quarters of the year, it is more consistent over time. It is important to note that pipeline and order growth is occurring despite resin prices moving higher and remaining at elevated levels. We expect demand to continue returning to more normalized levels as customers require our mission-critical equipment to fulfill growing end-market demand.
At the same time, we anticipate improved operating leverage and partial realization of ongoing cost actions to drive a return to more normalized profitability in the fourth quarter. Looking ahead, we're adjusting our full-year 2026 guidance while still expecting a sequentially strong fourth quarter, consistent with historical seasonality. For the fourth quarter, we now anticipate low single-digit organic revenue growth and high single-digit EBITDA growth at the midpoint of the range. For full-year 2026, we expect to achieve our prior revenue forecast from May, but are lowering the range for adjusted EBITDA and adjusted free cash flow due primarily to delayed realization of cost actions and mix at Husky, offsetting continued strong performance at CompoSecure. Tom will go deeper into our forward guidance, and Rob will provide more information than we would typically share regarding Husky.
I would note that while 2026 has been a foundational year for GPGI, we expect to see a return to our long-term growth algorithm next year and intend to grow GPGI's earnings and cash flow faster than the market to deliver superior, durable, through-the-cycle returns for our investors. As a reminder, the long-term growth algorithm we previously outlined is to deliver mid to high single-digit annual organic growth, over 100 basis points of annual margin expansion through the deployment of ROS, resulting in double-digit plus annual EBITDA growth. This performance is driven by our continued strategic investments in the businesses we own, doing the seed planting today that is necessary for them to achieve their potential tomorrow. ROS lies at the core of how we operate GPGI.
It is an end-to-end commitment to grow sales, control costs, and generate the cash necessary for accretive investing, which should compound returns for our investors. Businesses are a collection of connected processes, and we are highly focused on end-to-end improvement that translates operational efficiencies into durable financial performance. Graham and Rob will each discuss examples of how ROS is transforming CompoSecure and Husky, but I will emphasize how driving this daily mindset compounds performance over time. ROS is fundamentally a system designed to give businesses the necessary tools to become world-class operations that turn superior customer experiences into a catalyst for profitable growth. To conclude, we are making progress across the platform. Both CompoSecure and Husky are companies with great positions in good industries, and they are businesses we are proud to own.
We remain focused on execution to deliver in the fourth quarter, while also taking the necessary steps to position the platform for strong performance next year. With that, I'll turn it over to Tom Knott, our Chief Investment Officer.
Thank you, Dave. Going to slide four, GPGI delivered results in line with our expectations, with pro forma adjusted net sales of $509.6 million, up approximately 5% from the prior year, pro forma adjusted EBITDA of $146.3 million, up approximately 7% from the prior year, and pro forma adjusted EBITDA margins of 28.7%, up approximately 60 basis points from the prior year. GPGI also generated approximately $81 million in pro forma adjusted free cash flow in the third quarter, higher than the prior year. Turning to slide five, we are issuing guidance for the fourth quarter that reflects continued strength at CompoSecure, offset by the delayed realization of identified cost actions and margin headwinds at Husky.
We expect pro forma adjusted net sales to be between $630 million and $660 million, up approximately 1% from the prior year at the midpoint of the range, pro forma adjusted EBITDA between $178 million and $208 million, up approximately 8% from the prior year at the midpoint of the range, pro forma adjusted EBITDA margins between 27% and 29%, flat from the prior year at the midpoint of the range, and pro forma adjusted free cash flow between $77 million and $127 million. At a segment level, we anticipate CompoSecure to continue delivering strong revenue growth and profitability, with fourth quarter revenue growth in the high teens year-over-year.
For Husky, despite geopolitical uncertainty and elevated resin prices, we now expect a range of plus-minus low single-digit growth consistent with historical seasonality, coupled with sequential margin expansion driven by improved operating leverage, ROS-led efficiency gains, and the partial realizations of savings from ongoing cost actions. We are also adjusting our full year 2026 guidance. With better visibility into Husky's order book and delivery dates for the seasonally largest quarter of the year, we anticipate revenue to be on the higher end of our prior range and for GPGI to deliver low single-digit revenue growth year-over-year. Concurrently, we are lowering our outlook for adjusted EBITDA, margins, and free cash flow due to margin headwinds at Husky, primarily due to delayed realization of identified cost actions, product mix, higher freight costs, and continued investments necessary to position the business for growth in 2027 and beyond.
These investments partially offset some of the realized cost savings to date, as Rob will explain in more detail. Taken together, we expect pro forma adjusted net sales to be between $2.034 billion and $2.064 billion, up approximately 1% year-over-year at the midpoint of the range, pro forma adjusted EBITDA to be between $520 million and $550 million, down approximately 2% year-over-year at the midpoint of the range, pro forma adjusted EBITDA margins between 25% and 27%, down approximately 80 basis points year-over-year at the midpoint of the range, and pro forma adjusted free cash flow between $250 million and $300 million, reflecting healthy cash generation even with elevated growth CapEx. Importantly, despite the market-driven headwinds at Husky, we still anticipate full year growth across the recurring part of our business, aftermarket tooling, spare parts, and service contracts.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
8 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
